- Gupta G, Mammis A, Maniker A. Malignant Peripheral Nerve Sheath Tumors. Neurosurgery Clinics of North America. 2008; 19(4):533-43.
- Knight SWE, Knight TE, Santiago T, Murphy AJ, Abdelhafeez AH. Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management. Children (Basel). 2022; 9(1).
- Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, et al. Malignant peripheral nerve sheath tumors. Oncologist. 2014; 19(2):193-201.
- Pulliam S, Madwani K, Fox AD, El-Hachoum N, Ullah A, Patel N, et al. Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management. Cureus. 2022; 14(6):e26140.
- Kar M, Deo SVS, Shukla NK, Malik A, DattaGupta S, Mohanti BK, et al. Malignant peripheral nerve sheath tumors (MPNST) – Clinicopathological study and treatment outcome of twenty-four cases. World Journal of Surgical Oncology. 2006; 4(1):55.
- Arshi A, Tajudeen BA, St John M. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment Oral Oncol. 2015; 51(12):1088-94.
- Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021; 113(2):70-84.
- Amirian ES, Goodman JC, New P, Scheurer ME. Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program. J Neurooncol. 2014; 116(3):609-16.
- Salem RH, Almutairi OT, Bafaquh MS. Multifocal malignant peripheral nerve sheath tumor in patients with neurofibromatosis type I: Report of two cases and review of literature. Surg Neurol Int. 2023; 14: 261.
- Chen G, Liu Z, Su C, Guan Q, Wan F, Dong B, et al. Primary peripheral nerve sheath tumors of the thyroid gland: A case report and literature review. Mol Clin Oncol. 2016; 4(2):209-10.
- Balcerzak W, Dorobisz A, Czopnik P, editors. Malignant peripheral sheath tumour of the neck mimicking a thyroid tumour. A case report and a literature review from a reference centre for endocrine surgery2017.
- Treglia G, Taralli S, Bertagna F, Salsano M, Muoio B, Novellis P, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review. Radiol Res Pract. 2012; 2012: 431029.
- Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, et al. The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging. 2014; 41(9):1756-66.
- Tovmassian D, Abdul Razak M, London K. The Role of [(18)F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neuro-fibromatosis-1. Int J Surg Oncol. 2016; 2016:6162182.
- Warbey VS, Ferner RE, Dunn JT, Calonje E, O'Doherty MJ. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging. 2009; 36(5):751-7.
- Broski SM, Johnson GB, Howe BM, Nathan MA, Wenger DE, Spinner RJ, et al. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiol. 2016; 45(8):1097-105.
- Yadav D, Shamim SA, Rastogi S, Upadhyay DMR, Pandey AK, Kumar R. Role of 18F-FDG PET/computed tomography in prognosti-ation and management of malignant peripheral nerve sheath tumors. Nucl Med Commun. 2020; 41(9): 924-32.
- Van Lierop Z, Jentjens S, Anten M, Wierts R, Stumpel CT, Havekes B, et al. Thyroid Gland (18)F-FDG Uptake in Neurofibromatosis Type 1. Eur Thyroid J. 2018; 7(3):155-61.
- Nishida Y, Ikuta K, Ito S, Urakawa H, Sakai T, Koike H, et al. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/ longitudinal study. Cancer Sci. 2021; 112(3):1114-22.
|